ebomi
Colour theme
Sign in
Insider · CIK 0001277503

Kaneko Yasunori

CIK 0001277503 Name as filed on the most recent filing

Filed as Kaneko Yasunori (11)

12 transaction lines · from 11 filings · filed 2011-02-18 to 2025-02-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-02-27 P, Open-market purchase Arcus Biosciences, Inc.RCUS 201,200, acquired Open Form 4 filing 0001724521-25-000046
2021-04-23 P, Open-market purchase Arcus Biosciences, Inc.RCUS 129,652, acquired Open Form 4 filing 0001179110-21-004605
2018-10-19 P, Open-market purchase Si-Bone, Inc.SIBN 4,875,000, acquired Open Form 4 filing 0001209191-18-055698
2015-05-12 P, Open-market purchase Collegium Pharmaceutical, IncCOLL 1,800,000, acquired Open Form 4 filing 0001209191-15-042578
2015-02-20 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 976,583, disposed Open Form 4 filing 0001209191-15-018139
2014-10-27 S, Open-market sale Proteon Therapeutics IncPRTO 560,380, disposed Open Form 4 filing 0001104659-14-074955
2014-10-27 P, Open-market purchase Proteon Therapeutics IncPRTO 2,000,000, acquired Open Form 4 filing 0001104659-14-074955
2014-02-20 P, Open-market purchase Concert Pharmaceuticals, Inc.CNCE 2,100,000, acquired Open Form 4 filing 0001104659-14-012353
2014-02-04 P, Open-market purchase Dicerna Pharmaceuticals IncDRNA 3,000,000, acquired Open Form 4 filing 0001104659-14-006845
2013-03-25 P, Open-market purchase Tetraphase Pharmaceuticals IncTTPH 4,767,084, acquired Open Form 4 filing 0001181431-13-019221
2012-05-29 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 967,973, acquired Open Form 4 filing 0001104659-12-041088
2011-02-16 P, Open-market purchase Acelrx Pharmaceuticals IncACRX 6,179,715, acquired Open Form 4 filing 0001181431-11-011591

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KANEKO YASUNORI, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001277503

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.